Authors:
Gallagher-Thompson, D
Dal Canto, PG
Jacob, T
Thompson, LW
Citation: D. Gallagher-thompson et al., A comparison of marital interaction patterns between couples in which the husband does or does not have Alzheimer's disease, J GERONT B, 56(3), 2001, pp. S140-S150
Authors:
Thompson, LW
Coon, DW
Gallagher-Thompson, D
Sommer, BR
Koin, D
Citation: Lw. Thompson et al., Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression, AM J GER PS, 9(3), 2001, pp. 225-240
Authors:
Dodel, RC
Du, Y
Bales, KR
Gao, F
Eastwood, B
Glazier, B
Zimmer, R
Cordell, B
Hake, A
Evans, R
Gallagher-Thompson, D
Thompson, LW
Tinklenberg, JR
Pfefferbaum, A
Sullivan, EV
Yesavage, J
Altstiel, L
Gasser, T
Farlow, MR
Murphy, GM
Paul, SM
Citation: Rc. Dodel et al., alpha 2 macroglobulin and the risk of Alzheimer's disease, NEUROLOGY, 54(2), 2000, pp. 438-442
Authors:
Steffen, AM
Thompson, LW
Gallagher-Thompson, D
Koin, D
Citation: Am. Steffen et al., Physical and psychosocial correlates of hormone replacement therapy with chronically stressed postmenopausal women, J AG HEALTH, 11(1), 1999, pp. 3-26
Authors:
Kittlesen, DJ
Thompson, LW
Gulden, PH
Skipper, JCA
Colella, TA
Shabanowitz, J
Hunt, DF
Engelhard, VH
Slingluff, CL
Citation: Dj. Kittlesen et al., Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development (vol 160, pg 2099, 1998), J IMMUNOL, 162(5), 1999, pp. 3106-3106
Citation: Lh. Brinckerhoff et al., Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: Implications for peptide vaccines, INT J CANC, 83(3), 1999, pp. 326-334